Recently, the highly anticipated CPHI China 2026 concluded with great success. At this premier industry event gathering top enterprises and elites from the global pharmaceutical supply chain, KornnacCaps achieved a perfect finish to its exhibition journey, further elevating its brand influence in the international pharmaceutical excipients market, thanks to its diverse product matrix, exceptional quality, and professional service team.
Throughout the exhibition, the KornnacCaps booth was bustling with activity, attracting pharmaceutical representatives and purchasers from around the globe to stop by for consultations. At this year's event, KornnacCaps highlighted its comprehensive and multi-material capsule product portfolio, which includes the classic and high-quality gelatin capsules, Halal capsules catering to specific dietary and religious market needs, HPMC capsules and Pullulan capsules aligning with the trend for natural, plant-based concepts, as well as the specifically developed acid-resistant HPMC capsules.
This diverse and high-performance product line vividly demonstrated KornnacCaps's strong technical capabilities in meeting the formulation needs of various pharmaceutical preparations and dietary supplements. Notably, the acid-resistant HPMC capsules became a focal point of on-site discussions, thanks to their unique combination of plant-based attributes and targeted release technology. At the booth, the company's technical experts engaged in in-depth discussions with domestic and international clients regarding the application scenarios of different products, earning widespread acclaim.
As an innovator deeply rooted in the pharmaceutical capsule industry, KornnacCaps has always regarded "Quality First" and "Green Smart Manufacturing" as its core driving forces. Through the international platform of CPHI China, KornnacCaps not only delivered premium products that meet stringent international pharmacopeial standards to global clients but also conveyed its firm determination to promote the high-quality development of the pharmaceutical supply chain. During the exhibition, numerous new and existing customers reached preliminary cooperation intentions, laying a solid foundation for the company to deepen its global strategic layout.
Although the exhibition has come to a close, KornnacCaps's journey forward never stops. In the future, KornnacCaps will continue to stay true to its original mission, consistently increase its R&D investment, and continuously optimize its products and services. KornnacCaps looks forward to joining hands with global pharmaceutical colleagues to co-create a new chapter of prosperity in the industry and contribute greater "KornnacCaps strength" to the cause of human health.
